Document ID: chunk:federal_register_of_legislation:F2024L00045:reg:9:p6
Version: federal_register_of_legislation:F2024L00045
Segment Type: reg
Provision Reference: reg 9 (pt 6/6)
Character Range: 29189–31586

the 30 days before the clinical worsening of depressive disorder, where depressive disorder persists after the discontinuation or tapering of mefloquine or corticosteroid therapy;
(53)      using a psychoactive substance from the specified list of psychoactive substances at an intoxicant dose within the 30 days before the clinical worsening of depressive disorder;
Note: intoxicant dose and specified list of psychoactive substances are defined in the Schedule 1 – Dictionary.
(54)      taking a drug that cannot be ceased or substituted in the long term and which is associated in the individual with the worsening of depressive symptoms during drug therapy and either:
(a)          the improvement of depressive symptoms within days or weeks of discontinuing or tapering drug therapy; or
(b)          the worsening of depressive symptoms on rechallenge with the same drug;
where the drug was being taken within the 30 days before the clinical worsening of depressive disorder;
(55)      using a psychoactive chemical or substance at an intoxicant dose, which is associated in the individual with the worsening of depressive symptoms, and where the psychoactive chemical or substance was being taken within the 30 days before the clinical worsening of depressive disorder;
Note: intoxicant dose is defined in the Schedule 1 – Dictionary.
(56)      having ceased or reduced therapeutic or illicit drug use or other substance use within the 30 days before the clinical worsening of depressive disorder;
(57)      having an alcohol use disorder or a substance use disorder at the time of the clinical worsening of depressive disorder;
(58)      inhaling, ingesting or having cutaneous contact with organic solvents, in an unventilated and confined space, on more days than not for a continuous period of at least 5 years before the clinical worsening of depressive disorder, and where the clinical worsening occurs within 2 years of that period;
(59)      having an episode of acute cholinergic poisoning from exposure to an organophosphorus ester or paraquat poisoning within the 30 days before the clinical worsening of depressive disorder;
Note: acute cholinergic poisoning, organophosphorus ester and paraquat are defined in the Schedule 1 – Dictionary.
(60)      inability to obtain appropriate clinical management for depressive disorder before the clinical worsening of depressive disorder.